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Abstract
Antibiotics are likely the most important compounds used for human therapy. Conversely, antibiotic resistance is a relevant medical
problem. However, besides their relevance for human health, antibiotics and their resistance genes are important elements that can
inﬂuence the structure of microbial populations. In this article, we discuss antibiotics and antibiotic resistance genes in non-clinical envir-
omnents.
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Antibiotics (including synthetic antimicrobials) are probably
the most successful therapeutic agents developed by humans.
Although sulphonamides, the ﬁrst widely used antibiotics, are
synthetic, the large majority of these compounds have a nat-
ural origin. Furthermore, production of antibiotics is a fre-
quent characteristic of environmental microorganisms.
Conversely, antibiotic resistance is widely disseminated in
non-clinical environments, and antibiotic producers contain a
large number of antibiotic resistance genes in their genomes
[1] that might eventually be transferred to pathogenic bacte-
ria.
Antibiotic producers are able to outcompete, at least
under laboratory growing conditions, other microorganisms
[2]. Thus, a suitable ecological role for these molecules in
nature could be the Darwinian struggle for life against com-
petitors. As Waksman and Woodruff stated in 1940, the rea-
son for searching for antibiotic producers in soil was the
assumption that this type of organism must be present in the
environment and that production of antimicrobials should
have an ecological role in inhibiting the growth of other
microorganisms: ‘The soil was searched for bacterial agents
of infectious diseases, until the conclusion was reached that
these do not survive long in the soil. It was suggested that
the cause of the disappearance of these disease-producing
organisms in the soil is to be looked for among the soil-
inhabiting microbes, antagonistic to the pathogens and bring-
ing about their rapid destruction in the soil’ [3].
Following the same reasoning, the presence of large num-
bers of antibiotic resistance genes in natural (non-clinical)
environments strongly suggests that they must have an eco-
logical role, either in endogenous detoxiﬁcation in the case
of producer organisms, or in protecting bacteria from the
action of exogenous antimicrobials.
This ‘weapon/shield’ function for antibiotics and their
resistance genes is useful for pathogenic bacteria growing in
a treated host. This is an ecosystem with high concentrations
of antibiotics, where the unique function of these molecules
is to inhibit bacterial growth. Being resistant in an environ-
ment with a high load of antibiotics is a rewarding strategy
because it allows the utilization of resources in the absence
of competitors, which are being killed by the antimicrobial.
Antibiotic resistance can be considered as a colonization fac-
tor in the presence of antibiotics [4].
Do antibiotics and antibiotic resistance genes play the
same role in non-clinical environments? This may be true in
some instances, but compelling evidence indicates they may
have very different roles in mediating the interactions of
microbial communities in natural environments. There are
two important key concepts. First, the toxicity of a molecule
is always concentration-dependent. Furthermore, multiple
compounds are beneﬁcial at low concentrations and toxic at
high ones, an effect that has been called hormesis [5]. For
example, iron is a cofactor in several biomolecules and is
required for life. However, at high concentrations, iron is
toxic. For this reason, all organisms have developed complex
and exquisitely regulated mechanisms for acquiring iron and
avoiding its toxic effects. Second, production of antibiotics
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(and, thus, their concentrations in natural, non-clinical
environments) is highly regulated in the producer organisms
(a situation that obviously does not occur during clinical
treatment of infection). Similarly, the expression of antibiotic
resistance genes is ﬁnely tuned in the organisms in which
they evolve, whereas this regulation does not occur after
horizontal gene transfer to a pathogenic bacterium.
The concentrations of antibiotics in natural environments
is frequently too low to play their proposed functional role
as inhibitors of competitors. Antibiotics are frequently pro-
duced at stationary growth phase, not during active growth
when the production of a weapon to inhibit competitors
would be a rewarding ecological strategy. As antibiotics are
usually present at low concentrations in natural environ-
ments, studies on the effect of antibiotics at subinhibitory
concentrations may give insights into the role that these
molecules play in natural ecosystems [6]. These studies have
demonstrated that each antibiotic produces a rather speciﬁc
transcription pattern in global bacterial gene expression [7].
Functional analyses have also demonstrated that antibiotics
can trigger expression of phenotypes, such as bioﬁlm pro-
duction or cytotoxicity, that can give an ecological advantage
to bacteria growing under low antibiotic concentrations
[7,8]. From these studies, it has been suggested that antibiot-
ics may be signalling molecules mediating intercellular com-
munication in natural environments [8]. The more classic
role of ‘weapon’, with production of high concentrations of
antibiotic, might occur in some local micro-environments in
the rhizosphere.
If antibiotics are not always weapons, it is possible that
the natural function of some antibiotic resistance genes is
also other than to encode shields. Bacteria acquire resistance
by a few mechanisms (Fig. 1), some of them as the conse-
quence of mutations [9], and some due to horizontal gene
transfer [10]. The most frequent antibiotic resistance genes
acquired by horizontal gene transfer are antibiotic-inactivat-
ing enzymes and efﬂux pumps. It was earlier stated that ami-
noglycoside-inactivating enzymes could have a metabolic role,
in addition to a function in resistance, because ‘phosphory-
lated streptomycin might be important as a metabolic pre-
cursor’ [11]. More recent work has shown that some
aminoglycoside-modifying enzymes may be involved in acety-
lation of peptidoglycan [12]. The similar structure of the
enzymatic substrate and the antibiotic would allow these
enzymes to confer resistance even though they evolved to
play a completely different role. The investigation of
sequenced microbial genomes indicates that this could be a
frequent situation, because all bacteria contain in their gen-
ome antibiotic resistance genes, whether the bacteria pro-
duce antibiotics or not. As these genes are present in all
members of each species, they have not been acquired
recently by horizontal gene transfer as the consequence of
antibiotic pressure from antibiotics used by man and proba-
bly have functional roles different to resistance.
Multidrug resistance efﬂux pumps constitute another cate-
gory of antibiotic resistance genes for which a functional role
other than resistance has been proposed. Common sub-
strates of efﬂux pumps are the quinolones, and it has been
demonstrated that environmental bacteria isolated before
the discovery of these synthetic drugs were capable of
extruding quinolones [13]. Notably, some multidrug pumps
from Pseudomonas aeruginosa can extrude signal molecules
involved in quorum sensing in this bacterial species, including
one natural quinolone-like compound. Overexpression of
those pumps increases resistance to several antibiotics and
simultaneously leads to a reduction in the quorum sensing
response and virulence [14–16]. It is thus likely that these
efﬂux pumps might be involved in the bacterial response to
intercellular signalling.
In summary, we propose that antibiotics may be signalling
molecules (and not only weapons) in natural environments.
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Fig. 1. Mechanisms of antibiotic resistance: (A) A schematic repre-
sentation of a Gram-negative bacterium with two membranes. To
inhibit microbial growth, an antibiotic needs to cross the cellular
envelopes (1 and 2), on some occasions to be modiﬁed (3) and to
reach its target (4) at concentrations high enough for its effective
binding. (B) Mutations in all the elements involved in this pathway
can produce resistance because the membrane transporters suffer
structural changes (a) or are not expressed (c), because there is a
modiﬁcation (e), or lack of expression of, the enzyme that activates
the pre-antibiotic or because the target presents structural modiﬁca-
tions (f) that impede the antibiotic’s binding. Antibiotic-inactivating
enzymes (b) and efﬂux pumps (d), either present in the bacterial ge-
nomes or acquired by horizontal gene transfer, also contribute
greatly to antibiotic resistance.
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Conversely, antibiotic resistance genes could have metabolic
roles (and act not only as shields) that may include biosyn-
thesis of macromolecules, maintenance of homeostasis, and
signal trafﬁcking.
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